Actuate TherapeuticsACTU
13F holders, Q3 2024 (September 30)10holders
$7.45avg. 13F price*
At the end of Q3 2024, 10 institutions reported holding Actuate Therapeutics Inc. (ACTU) in their 13F filings. The largest holders were AWM Investment Company, Inc. ($1.0M), Long Corridor Asset Management Ltd ($931K) and Royal Bank of Canada ($263K).
- Company
- Actuate Therapeutics Inc.
- CUSIP
- 005083100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $2.8M |
| Exits | 0 | $0 |
Ownership 10 holders
| AWM Investment Company, Inc. | 0.13% | New | 139,511 | $1.0M |
| Long Corridor Asset Management Ltd | 1.05% | New | 125,000 | $931K |
| Royal Bank of Canada | 0.00% | New | 35,300 | $263K |
| Geode Capital Management, LLC | 0.00% | New | 27,893 | $208K |
| Northwestern University | 0.24% | New | 27,778 | $207K |
| KG Capital Management | 0.03% | New | 12,000 | $89K |
| Citigroup Inc. | 0.00% | New | 10,973 | $82K |
| Wells Fargo & Company | 0.00% | New | 3,392 | $25K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 297 | $2K |
| Bank of America Corp. | 0.00% | New | 23 | $171 |
"% of holder's portfolio" is ACTU's weight in each manager's 13F, not the share of Actuate Therapeutics Inc. the manager owns.